Based on the results of prognostic analysis and clinical characterization, we hypothesized that the low expression level of LINC00528 at the late stage is likely to be an important factor for the late metastasis of HER2-positive breast cancer. The gene discussed is LINC00528; the disease is breast carcinoma.